Linan Fang

Dr. Linan Fang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
DLDalam Ly
Dalam Ly
Quan LiQuan Li
Quan Li
RNRoya Navab
Roya Navab
CZCédric Zeltz
Cédric Zeltz
LFLinan Fang
Linan Fang
LZLi Zhang
Li Zhang
Cancer development requires a permissive microenvironment that is shaped by interactions between tumor cells, stroma, and the surrounding matrix. As collagen receptors, the leukocyte-associated immunoglobulin-like receptor (LAIR) family allows the immune system to interact with the extracellular matrix. However, little is known about their role in regulating tumor immunity and cancer progression. Methods: Genetic analysis of resected human lung adenocarcinoma was correlated to clinical-pathological characteristics, gene ontologies, and single cell RNA sequencing (scRNASeq). LAIR2 production was determined in subsets of immune cells isolated from blood leukocytes and lung adenocarcinoma tumor. Functional assays were used to determine the role of LAIR2 in tumorigenesis. Results: LAIR2 expression was adversely prognostic in lung adenocarcinoma. LAIR2 was preferentially produced by activated CD4+ T cells and enhanced in vitro tumor invasion into collagen. scRNASeq analysis of tumor infiltrating T cells revealed that LAIR2 expression co-localized with FOXP3 expressing cells and shared a transcriptional signature with tumor-associated regulatory T (Treg) cells. A CD4+ LAIR2+ Treg gene signature was prognostically significant in the TCGA dataset (n = 439; hazard ratio (HR) = 1.37; 95% confidence interval (CI), 1.05–1.77, p = 0.018) and validated in NCI Director’s Challenge lung adenocarcinoma dataset (n = 488; HR = 1.54; 95% CI, 1.14–2.09, p = 0.0045). Conclusions: Our data support a role for LAIR2 in lung adenocarcinoma tumorigenesis and identify a CD4+ LAIR2+ Treg gene signature in lung adenocarcinoma prognosis. LAIR2 provides a novel target for development of immunotherapies.

10 January 2023 in Talanta
Verified
Journal Article
Closed access
ZWZe Wang
Ze Wang
ALAnnan Liu
Annan Liu
XLXingchen Li
Xingchen Li
LGLin Guan
Lin Guan
HXHuiyuan Xing
Huiyuan Xing
QLQuan Lin
Quan Lin

25 November 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
YSYuqi Song
Yuqi Song
JZJinming Zhang
Jinming Zhang
LFLinan Fang
Linan Fang
WLWei Liu
Wei Liu
Background: Necroptosis is a phenomenon of cellular necrosis resulting from cell membrane rupture by the corresponding activation of Receptor Interacting Protein Kinase 3 (RIPK3) and Mixed Lineage Kinase domain-Like protein (MLKL) under programmed regulation. It is reported that necroptosis is closely related to the development of tumors, but the prognostic role and biological function of necroptosis in lung adenocarcinoma (LUAD), the most important cause of cancer-related deaths, is still obscure.Methods: In this study, we constructed a prognostic Necroptosis-related gene signature based on the RNA transcription data of LUAD patients from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases as well as the corresponding clinical information. Kaplan-Meier analysis, receiver operating characteristic (ROC), and Cox regression were made to validate and evaluate the model. We analyzed the immune landscape in LUAD and the relationship between the signature and immunotherapy regimens.Results: Five genes (RIPK3, MLKL, TLR2, TNFRSF1A, and ALDH2) were used to construct the prognostic signature, and patients were divided into high and low-risk groups in line with the risk score. Cox regression showed that risk score was an independent prognostic factor. Nomogram was created for predicting the survival rate of LUAD patients. Patients in high and low-risk groups have different tumor purity, tumor immunogenicity, and different sensitivity to common antitumor drugs.Conclusion: Our results highlight the association of necroptosis with LUAD and its potential use in guiding immunotherapy.

28 January 2022 in Talanta
Verified
Journal Article
Closed access
YLYangliu Lin
Yangliu Lin
YZYueqi Zhao
Yueqi Zhao
ZYZhe Yang
Zhe Yang
ZSZhubin Shen
Zhubin Shen
JKJunran Ke
Junran Ke
QLQuan Lin
Quan Lin

17 January 2022 in Applied Optics
Verified
Journal Article
Closed access
PDF file
YLYang Luo
Yang Luo
LFLinan Fang
Linan Fang
WWWei-Hua Wei
Wei-Hua Wei
WGWei Guan
Wei Guan
YDYun-Zhi Dai
Yun-Zhi Dai
BGBingrong Gao
Bingrong Gao
Switchable and reversible optical elements have potential applications in self-adaptive optics. Shape-memory polymer devices with adaptive properties could be easily switched under environment or field stimuli. Here, the laser beam interference technique was used to realize the periodic grating structures of the shape-memory polymer, and memory and recovery of the grating structures were performed. A one-dimensional grating structure was fabricated from dual-beam interference lithography of a nanosecond laser and underwent pressure in a condition of 195°C. The vertical height of the grating was reduced, and the diffraction light was weakened. When the sample was cooled down to room temperature, the morphology of the grating could be kept. After raising the ambient temperature of the sample to 120°C, the morphology of the grating was recovered to the original state, which realized the shape-memory function.

18 November 2022 in Medicine
Verified
Journal Article
Open access
YSYifeng Shao
Yifeng Shao
MTMingbo Tang
Mingbo Tang
LFLinan Fang
Linan Fang
SWShixiong Wei
Shixiong Wei
XGXinliang Gao
Xinliang Gao
WLWei Liu
Wei Liu
Background: Whether the size of thymic epithelial tumors (TETs) has an impact on prognosis has long been a controversial issue. Our study was designed to investigate the value of tumor size in the prognosis (overall survival (OS) and relapse-free survival) of patients with TETs. Methods: We searched the databases such as PubMed, EMBASE, Web of Science, and clinical trials registration system for articles illustrating the impact of tumor size on survival data in TETs patients. We did a meta-analysis for OS and relapse-free survival. Results: We recruited 9 studies in our meta-analysis. Our study illustrates that TETs patients with small tumor size had better relapse-free survival (hazard ratio = 1.66, 95% confidence interval 1.18–2.35, P = .004) and OS (hazard ratio = 1.93, 95% confidence interval 1.30–2.80, P = .001) in comparison to patients with large tumor size. Conclusions: In conclusion, the results of our meta-analysis showed that TET size was significantly associated with overall and relapse-free survival of patients, with relatively small tumors tending to have a better prognosis.